Coronavirus: This scanning electron microscope image shows SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab. Credit: NIAID-RML.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Related Company Profiles

View all

US-based biotechnology company Integral Molecular will leverage its technology platforms to identify Covid-19 vaccines and therapeutics.

Shotgun Mutagenesis Epitope Mapping and the Membrane Proteome Array will be used to gain insights into the human immune response to the novel coronavirus.

The company will also utilise the platforms to discover cellular receptors that could provide information on the rapid spread of the virus.

Integral Molecular president Benjamin Doranz said: “Deep expertise in virology is at the core of Integral Molecular’s nearly 20-year history, including our contributions to discovering the receptor for HIV and other viruses.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We have the ability to use our unique tools to help curb the spread of this deadly virus and have initiated research efforts on multiple fronts to aid in the global effort for a coronavirus vaccine.”

During previous emerging epidemics such as Ebola and Zika, Integral Molecular supported discovery efforts for vaccines and therapeutics.

The Shotgun Mutagenesis Epitope Mapping technology mapped more than 1,000 antibody binding sites to date, while the Membrane Proteome Array platform helped find various receptors used by viruses to infect cells.